A Phase Ii Study of THP (Pirarubicin)-Cop Therapy in Patients With Newly Diagnosed Advanced Ptcl: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group
Hematological Oncology - United Kingdom
doi 10.1002/hon.147_2631
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley